Board documents
10-11 November 2010

Board Meeting 14

World Health Organization Geneva, Switzerland.

Minutes:

Resoultions:

R20 - Unitaid Executive Director
R19 - Executive Director performance review
R18 - Unitaid Board representation on AMFm Committee
R17 - Framework on Unitaid Communication Strategy
R15 - Medicines Patent Pool Foundation Cost extension for 2011
R13 - Committee chairs of the Policy Strategy Committee (PSC) and Finance and Administration Committee (FAC)
R12 - Launch of call for Letters of Intent
R11 - Independent Steering Committee (ISC) of the 5-year evaluation of Unitaid
R10 - Process for revision of Unitaid Board Committee terms of reference
R9 - Unitaid by-laws
R8 - Unitaid constitution
R7 - Unitaid finance policies (1 to 3)
R6 - Resource mobilization objectives for 2011
R5 - Revised budget 2011
R4 - 2010 Financial report
R3 - Revised proposal submission and review procedures
R2 - Key performance indicators 2011-2012
R1 - Key performance indicators 2010
10-11 November 2010

Board Meeting 13

World Health Organization Geneva, Switzerland.

Minutes:

Resoultions:

R16 - Board retreat and partnership meeting
R11 - Board operating procedures
R15 - Improved HIV/AIDS monitoring
R14 - Partnership for a sustainable access to quality and affordable viral load testing
R13 - Unitaid-funded paedriatic HIV/AIDS treatment project – extension for the period 2011-2012
R12 - Annex
R12 - Advisory Group on Funding Priorities
R10 - The Resource Mobilization Task Force – Budget 2011
R9 - Office of the Chair of the Executive Board – budget 2011
R8 - Positions reporting directly to Executive Secretary
R7 - Second Unitaid Paedriatic TB Project
R6 - Key Performance Indicators 2010
R5 - Election of the Chair of the Executive Board
R4 - Budget 2011
R3 - Prioritization framework
R2 - M&E framework
R1 - Support to the civil society delegations
EB13 - Operations update
R11 - Annex
08-09 June 2010

Board Meeting 12

World Health Organization Geneva, Switzerland.

Minutes:

Resoultions:

R18 - FIND quality-assured scale-up of malaria rapid diagnostic tests
R17 - FIND single-step diagnostic of tuberculosis
R16 - Malaria No More financing mechanism accelerating access to malaria commodities
R15 - SMILE access to female condom
R14 - Effective treatment of malaria with artemisinin-based combination therapies – CNHDE
R13 - Resource mobilization for Air Ticket Levy
R12 - Paediatric tuberculosis extension
R11 - Paediatric HIV/AIDS extension
R10 - Preventing mother-to-child transmission of HIV (PMTCT) extension
R9 - Executive Board membership: Spain
R8 - Recommendations of the Governance Working Group on the Election of the Executive Board Chair
R7 - Memorandum of Understanding between Unitaid and Medicines Patent Pool Foundation
R6 - Key performance Indicators 2010-2012
R5 - Human-resource plan
R4 - Revised budget 2010
R3 - Audited financial report 2008-2009
R2 - Establishment of the Proposal Review Committee (PRC)
R1 - Key performance indicators 2009
14-15 December 2009

Board Meeting 11

World Health Organization Geneva, Switzerland.

Minutes:

Resoultions:

R13 - Election of the Chair
R12 - Governance
R11 - Support to CS delegations
R10 - Dates of Official Meetings 2010
R9 - Revision of Annex B to Unitaid-WHO Memorandum of Understanding (Fees)
R8 - AMFM Vice Chair
R7 - CHAI Paediatric ARV – 2010 budget
R6 - Office of the chair
R5 - Implementation of patent pool
R3 - Financial update 30 September 2009
R2 - Establishment of an advisory group on priorities for funding (AGPF)
R1 - Endorsement of Unitaid overall strategy
12-13 May 2009

Board Meeting 10

World Health Organization Geneva, Switzerland.

Resoultions:

R19 - Additional board operating procedures
R18 - Unitaid name protection
R17 - Review of Unitaid governing documents
R16 - Vice-Chair
R15 - Patent Pool
R13 - Evaluation of Unitaid-supported projects
R12 - Finalisation of Unitaid strategy document
R11 - Action name: harmonization of CHAI second Line ARV project budget Document Type Resolutions
R10 - Action name: extension of CHAI second line ARV project
R9 - Action name: procurement of MDR-TB drugs for approved Global Fund Grant recipients in round 8 and RCC4 based on direct disbursement to GDF
R8 - Action name: proposal for extension of the project narrowing the gap – expanding and accelerating access to diagnostics for patients at risk of MDR-TB
R7 - Action name: second amendment to the GDF/GLC/GF MDR-TB scale-up initiative
R6 - PRC nominations sub-committee tasks
R5 - Office of the Chair of the Executive Board – Budget 2009
R4 - Budget 2009
R3 - Unaudited Financial Report 2008
R2 - Unaudited financial report 2006-2007
R1 - Financial Commitments

Documents:

Chair Summary
29 January 2009

Board Meeting 09

World Health Organization Geneva, Switzerland.

Documents:

Chair’s summary
02-03 July 2008

Board Meeting 08

Geneva, Switzerland.

Minutes:

Resoultions:

R11 - Office of the Chair of the Executive Board
R10 - Implementation of the voluntary solidarity contribution (VSC) project
R9 - Patent Pool
R8 - Development for a process and a set of tools to validate partners’ capacities and readiness to implement Unitaid-approved projects
R7 - Request for expansion of MDR-TB scale-up Initiative
R6 - Request for expansion and extension of paediatric TB project
R5 - Public health approach to intellectual property
R4 - Prequalification of diagnostics
R2 - HIV/AIDS PMTCT
R1 - Safeguarding availability of ARV treatment

Documents:

Chair’s summary
EB8 Special session
06-07 December 2007

Board Meeting 07

Brasilia, Brazil.

Minutes:

Resoultions:

R14 - Followup resolution
R13 - Statute of the Chairperson of the Executive Board
R10 - Evolution of secretariat functions
R9 - AMFm
R7 - Development process for the submission and appraisal of proposals and concept notes
R6 - Project support for quality assurance of medicines, 2008-2012
R5 - Project Acceleration of nutritional care of pregnant and lactating women and children linked to PMTCT: address nutritional problems that impact negatively on PMTCT outcomes, 2008-2010
R4 - Project expanding and accelerating access to diagnostics for patients at risk of multi-drug resistant Tuberculosis (MDR-TB)
R3 - Project multi-drug resistant (MDR)-TB scale-up and acceleration of access: 2008-2011
R2 - Development of a strategic plan 2009-2011
R1 - Tuberculosis strategic orientation

Documents:

Chair summary
1 3 4 5 6

2023

June

R13-2023-e

Extension for the Project “Rapid, comprehensive targeted gene sequencing solution for drug-resistant TB diagnosis in LMICs”

R7-2023-e

Governance Working Group Appointment of members

May

R5-2023-e

Cost Extension for the Project ‘Preventing deaths from cervical cancer by catalysing the use of optimal screening tests and treatment devices’

R4-2023-e

Go-ahead for the development of grant agreement packages on Preventing deaths among adults and children by simplifying Advanced HIV Disease management for proposed projects with Clinton Health Access Initiative (CHAI) and The Aurum Institute

R3-2023-e

Governance Working Group Appointment of Chair and Vice-Chair

R2-2023-e

Additional contribution from Canada

R1-2023-e

Contribution from Portugal

2022

December

R24-2022-e

Amendment to WHO Enabler Grant

1 3 4 5 6 7 26

No posts found.